Drugs & medicalClass II

TAILSTORM HEALTH INC recalls Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by…

Subpotent Drug: reduced efficacy for epinephrine

Read the official notice →
Date
2024-07-17
Country
United States
Brand
Tailstorm Health
Product
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by…
Classification
Class II
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Tailstorm Health recalls

  1. 2025-07-09
  2. US
    Drugs & medicalClass II

    Tailstorm Health INC recalls KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office…

    Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

    FDA · DrugTailstorm Health INCNationwide in the USOfficial notice →
  3. 2024-11-27
  4. US
All 3 Tailstorm Health recalls →

Other drugs & medical recalls in the United States

  1. 2024-07-17
  2. US
    Drugs & medicalClass I

    Synergetics Inc recalls BAUSCH+LOMB, I-PACK Injection Kit, REF 18060, for the administration of intravitreal injection (eye)

    Sterilization certificates could not be validated by the supplier

    FDA · DeviceSynergetics IncUS NationwideOfficial notice →
  3. US
    Drugs & medicalClass III

    Rising Pharma Holding, Inc. recalls Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising…

    Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

    FDA · DrugRising Pharma Holding, Inc.Nationwide in the USAOfficial notice →
  4. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India,…

    Cross contamination with other products

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USA and Puerto RicoOfficial notice →
  5. US
    Drugs & medicalClass III

    Zydus Pharmaceuticals (USA) Inc recalls Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC:…

    Cross contamination with other products.

    FDA · DrugZydus Pharmaceuticals (USA) IncNationwide in the USAOfficial notice →
  6. US
    Drugs & medicalClass II

    Equibal Inc recalls Blemfree All Day Lotion (salicylic acid 0.5% w/w), packaged in a) 1 oz. 29 ML tube NDC:53228-003-01 b) 4 OZ 118ML plastic bottle, UPC 7…

    CGMP Deviations: Manufactured without following Current Good Manufacturing Practises.

    FDA · DrugEquibal IncNationwide in the USA via internet sales.Official notice →
  7. US
    Drugs & medicalClass II

    Amerisource Health Services LLC recalls buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only,…

    Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

    FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
See all drugs & medical recalls →